Category: Diagnostics

Diagnostics, Press Releases

XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business Opportunities

Oct 5, 2022

Vancouver, Canada, and Uttenweiler, Germany (October 4, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report...

Continue Reading

Diagnostics, Press Releases

XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease

Jul 18, 2022

Vancouver, Canada, and Uttenweiler, Germany (July 18, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report...

Continue Reading

Diagnostics, Press Releases

XPhyto, Biosensors market and product developments on platform-based oral dissolvable biosensors for oral health and infectious disease

Apr 12, 2022

Vancouver, Canada, and Uttenweiler, Germany (April 11, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...

Continue Reading

Diagnostics, Press Releases

XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as part of Multi-Product Rollout Strategy

Feb 1, 2022

Vancouver, Canada, and Uttenweiler, Germany (February 1, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Diagnostics, Press Releases

XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia

Jan 13, 2022

Vancouver, Canada, and Uttenweiler, Germany (January 13, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Diagnostics, Press Releases

XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab

Sep 8, 2021

Vancouver, Canada, and Frankfurt, Germany (September 08, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Diagnostics, Press Releases

XPhyto’s acquisition target, 3a-diagnostics, reports breakthrough identification of COVID-19 biosensor candidates

Jul 28, 2021

First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto’s oral dissolvable delivery platformBiosensor candidates are ready for optimization and performance assessmentDevelopment of...

Continue Reading

Diagnostics, Press Releases

XPhyto signs transformative acquisition agreement with 3a-diagnostics, to enter hi-tech biosensor market and expand its diagnostic product portfolio

Jul 20, 2021

The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products.The acquisition secures...

Continue Reading

Diagnostics, Press Releases

XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test

Jun 30, 2021

XPhyto signs master supply agreement with operator of 10 COVID-19 test centersThe test will be offered to customers as a rapid PCR test with sample...

Continue Reading

Diagnostics, Press Releases

XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany

May 7, 2021

Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logisticsProject is in cooperation with a German pharmacy currently running a COVID-19...

Continue Reading

Diagnostics, Press Releases

XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test

Apr 28, 2021

XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval. Potential customers include government institutions, private healthcare providers...

Continue Reading

Diagnostics, Press Releases

XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test

Apr 21, 2021

XPhyto has entered into an agreement with an established German pharmaceutical wholesaler and service provider for the distribution, storage and logistics of XPhyto's diagnostic products...

Continue Reading